Assenagon Asset Management S.A. 13D/13G Filings for Minerva Neurosciences, Inc. (NERV)

Assenagon Asset Management S.A. 13D and 13G filings for Minerva Neurosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-11-24
09:13 am
Sale
2021-11-2413GMinerva Neurosciences, Inc.
NERV
Assenagon Asset Management S.A.173,186
3.240%
-586,978decrease
(-77.22%)
Filing
2021-11-24
09:11 am
Purchase
2021-11-2313GMinerva Neurosciences, Inc.
NERV
Assenagon Asset Management S.A.760,164
14.230%
760,164increase
(New Position)
Filing